Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis

Inflammatory Bowel Diseases

Volumn 19, Issue 6, 2013, Pages 1232-1237

  Raina, Amit ^a   Yadav, Dhiraj ^a   Regueiro, Miguel ^a   Krasinskas, Alyssa M ^a   Saul, Melissa I ^b   Sapienza, Dee Ann M ^a   Binion, David G ^a   Hartman, Douglas J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Colitis; Crohn's Disease; IBD; IgG4; Primary sclerosing cholangitis; PSC; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN G4; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; CELL INFILTRATION; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROSCOPY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECTUM BIOPSY; RETROSPECTIVE STUDY; REVIEW; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PLASMA CELLS; PROGNOSIS; YOUNG ADULT;

EID: 84879195691     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318281344d     Document Type: Review

References (26)

1. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948-3955.
2. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 366: 539-551.
3. Zhang L, Lewis JT, Abraham SC, et al. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol. 34: 88-94.
4. Tsubata Y, Akiyama F, Oya T, et al. IgG4-related chronic tubulointerstitial nephritis without autoimmune pancreatitis and the time course of renal function. Intern Med. 49:1593-1598.
5. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715.
6. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104:2295-2306.
7. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4: 1010-1016; quiz 934.
8. Zhang L, Chari S, Smyrk TC, et al. Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas. 40:1172-1179.
9. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 40:352-358.
10. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol. 2007;42(suppl 18):39-41.
11. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006; 30:1537-1545.
12. Dhall D, Suriawinata AA, Tang LH, et al. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 41:643-652.
13. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20: 23-28.
14. Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 40:809-814.
15. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 139:140-148; quiz e12-e3.
16. Ravi K, Chari ST, Vege SS, et al. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis. 2009;15:1326-1330.
17. Navaneethan U, Venkatesh PG, Kapoor S, et al. Elevated serum IgG4 is associated with chronic antibiotic-refractory pouchitis. J Gastrointest Surg. 15:1556-1561.
18. Navaneethan U, Bennett AE, Venkatesh PG, et al. Tissue infiltration of IgG4+ plasma cells in symptomatic patients with ileal pouch-anal anastomosis. J Crohns Colitis. 5:570-576.
19. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070-2075.
20. Bjornsson E, Chari S, Silveira M, et al. Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy. Am J Ther. 18:198-205.
21. Yount RJ, Vries JK, Councill CD. The medical archival system: an information retrieval system based on distributed parallel processing. Inf Process Manag. 1991;27:379-389.
22. Hefti MM, Chessin DB, Harpaz NH, et al. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum. 2009;52:193-197.
23. Rebours V, Le Baleur Y, Cazals-Hatem D, et al. Immunoglobulin G4 immunostaining of gastric, duodenal, or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol. 10:91-94.
24. van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Antiinflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317:1554-1557.
25. Gordon JN, Pickard KM, Di Sabatino A, et al. Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:195-203.
26. Hartman HJ, Binion DG. Distribution of IgG4 cells in medically refractory patients with inflammatory bowel disease. Gastroenterology. 2012; 142(Suppl 1):S-789.